Xtant Medical Holdings, Inc.

NYSEAM:XTNT Stock Report

Market Cap: US$72.0m

Xtant Medical Holdings Future Growth

Future criteria checks 1/6

Xtant Medical Holdings is forecast to grow earnings and revenue by 56.3% and 15.2% per annum respectively while EPS is expected to grow by 56.4% per annum.

Key information

56.3%

Earnings growth rate

56.4%

EPS growth rate

Medical Equipment earnings growth17.3%
Revenue growth rate15.2%
Future return on equityn/a
Analyst coverage

Low

Last updated18 Oct 2024

Recent future growth updates

Recent updates

Shareholders Are Thrilled That The Xtant Medical Holdings (NYSEMKT:XTNT) Share Price Increased 186%

Mar 02
Shareholders Are Thrilled That The Xtant Medical Holdings (NYSEMKT:XTNT) Share Price Increased 186%

Earnings and Revenue Growth Forecasts

NYSEAM:XTNT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261655N/AN/A1
12/31/2025134-5-3-12
12/31/2024118-13-16-132
6/30/2024111-3-18-16N/A
3/31/2024101-2-15-13N/A
12/31/2023911-11-10N/A
9/30/2023783-12-11N/A
6/30/202368-9-11-9N/A
3/31/202363-8-8-7N/A
12/31/202258-8-7-5N/A
9/30/202257-9-5-3N/A
6/30/202256-8-3-1N/A
3/31/202256-7-11N/A
12/31/202155-5-20N/A
9/30/202155-3-11N/A
6/30/202156-302N/A
3/31/202151-5-20N/A
12/31/202053-7-2-1N/A
9/30/202056-8-3-2N/A
6/30/202058-8-4-3N/A
3/31/202063-8-4-3N/A
12/31/201965-8-10N/A
9/30/201966-6312N/A
6/30/201968-6512N/A
3/31/201971-6811N/A
12/31/201872-7011N/A
9/30/201873-42-10N/A
6/30/201876-4701N/A
3/31/201878-52N/A-1N/A
12/31/201783-52N/A-1N/A
9/30/201788-29N/A-4N/A
6/30/201791-25N/A-7N/A
3/31/201791-20N/A-15N/A
12/31/201690-19N/A-14N/A
9/30/201688-3N/A-11N/A
6/30/201682-5N/A-13N/A
3/31/201671-4N/A-6N/A
12/31/201559-2N/A-9N/A
9/30/201546-17N/A-11N/A
6/30/201537-12N/A-8N/A
3/31/201536-11N/A-7N/A
12/31/201435-11N/A-7N/A
9/30/201435-11N/A-5N/A
6/30/201434-15N/A-5N/A
3/31/201433-15N/A-5N/A
12/31/201333-13N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: XTNT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: XTNT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: XTNT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: XTNT's revenue (15.2% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: XTNT's revenue (15.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if XTNT's Return on Equity is forecast to be high in 3 years time


Discover growth companies